Global Proliferative Diabetic Retinopathy Therapeutics Market Insights, Forecast to 2028

Q: Who are the key players in the proliferative diabetic retinopathy therapeutics market?

Some of the key players are Acucela Inc, Aerie Pharmaceuticals Inc., Antisense Therapeutics Ltd, Icon Bioscience Inc, Ohr Pharmaceutical Inc, PanOptica Inc, Ribomic Inc, ThromboGenics NV, Company, China, Others.

Code: QYRE-Auto-10T514

Report

February 2022

Pages:90

QYResearch

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

Acucela Inc

Aerie Pharmaceuticals Inc.

Antisense Therapeutics Ltd

Icon Bioscience Inc

Ohr Pharmaceutical Inc

Market Analysis and Insights: Global Proliferative Diabetic Retinopathy Therapeutics Market

The global Proliferative Diabetic Retinopathy Therapeutics market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Ocriplasmin accounting for % of the Proliferative Diabetic Retinopathy Therapeutics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospital segment is altered to an % CAGR throughout this forecast period.

China Proliferative Diabetic Retinopathy Therapeutics market size is valued at US$ million in 2021, while the North America and Europe Proliferative Diabetic Retinopathy Therapeutics are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Proliferative Diabetic Retinopathy Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Proliferative Diabetic Retinopathy Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Proliferative Diabetic Retinopathy Therapeutics market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Proliferative Diabetic Retinopathy Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Proliferative Diabetic Retinopathy Therapeutics market.

Global Proliferative Diabetic Retinopathy Therapeutics Scope and Market Size

Proliferative Diabetic Retinopathy Therapeutics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Proliferative Diabetic Retinopathy Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Ocriplasmin

PAN-90806

RBM-008

Squalamine Lactate

THR-687

Others

Segment by Application

Hospital

Clinic

Home Care

BY COMPANY

Acucela Inc

Aerie Pharmaceuticals Inc

Antisense Therapeutics Ltd

Icon Bioscience Inc

Ohr Pharmaceutical Inc

PanOptica Inc

Ribomic Inc

ThromboGenics NV

BY REGION

North America

United States

Canada

Europe

Germany

France

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

FEATURED COMPANIES

Acucela Inc

Aerie Pharmaceuticals Inc.

Antisense Therapeutics Ltd

Icon Bioscience Inc

Ohr Pharmaceutical Inc

1 Report Business Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Proliferative Diabetic Retinopathy Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Ocriplasmin

1.2.3 PAN-90806

1.2.4 RBM-008

1.2.5 Squalamine Lactate

1.2.6 THR-687

1.2.7 Others

1.3 Market by Application

1.3.1 Global Proliferative Diabetic Retinopathy Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Home Care

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Proliferative Diabetic Retinopathy Therapeutics Market Perspective (2017-2028)

2.2 Proliferative Diabetic Retinopathy Therapeutics Growth Trends by Region

2.2.1 Proliferative Diabetic Retinopathy Therapeutics Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Proliferative Diabetic Retinopathy Therapeutics Historic Market Size by Region (2017-2022)

2.2.3 Proliferative Diabetic Retinopathy Therapeutics Forecasted Market Size by Region (2023-2028)

2.3 Proliferative Diabetic Retinopathy Therapeutics Market Dynamics

2.3.1 Proliferative Diabetic Retinopathy Therapeutics Industry Trends

2.3.2 Proliferative Diabetic Retinopathy Therapeutics Market Drivers

2.3.3 Proliferative Diabetic Retinopathy Therapeutics Market Challenges

2.3.4 Proliferative Diabetic Retinopathy Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Proliferative Diabetic Retinopathy Therapeutics Players by Revenue

3.1.1 Global Top Proliferative Diabetic Retinopathy Therapeutics Players by Revenue (2017-2022)

3.1.2 Global Proliferative Diabetic Retinopathy Therapeutics Revenue Market Share by Players (2017-2022)

3.2 Global Proliferative Diabetic Retinopathy Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Proliferative Diabetic Retinopathy Therapeutics Revenue

3.4 Global Proliferative Diabetic Retinopathy Therapeutics Market Concentration Ratio

3.4.1 Global Proliferative Diabetic Retinopathy Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Proliferative Diabetic Retinopathy Therapeutics Revenue in 2021

3.5 Proliferative Diabetic Retinopathy Therapeutics Key Players Head office and Area Served

3.6 Key Players Proliferative Diabetic Retinopathy Therapeutics Product Solution and Service

3.7 Date of Enter into Proliferative Diabetic Retinopathy Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Proliferative Diabetic Retinopathy Therapeutics Breakdown Data by Type

4.1 Global Proliferative Diabetic Retinopathy Therapeutics Historic Market Size by Type (2017-2022)

4.2 Global Proliferative Diabetic Retinopathy Therapeutics Forecasted Market Size by Type (2023-2028)

5 Proliferative Diabetic Retinopathy Therapeutics Breakdown Data by Application

5.1 Global Proliferative Diabetic Retinopathy Therapeutics Historic Market Size by Application (2017-2022)

5.2 Global Proliferative Diabetic Retinopathy Therapeutics Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Proliferative Diabetic Retinopathy Therapeutics Market Size (2017-2028)

6.2 North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Type

6.2.1 North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2017-2022)

6.2.2 North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2023-2028)

6.2.3 North America Proliferative Diabetic Retinopathy Therapeutics Market Share by Type (2017-2028)

6.3 North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Application

6.3.1 North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2017-2022)

6.3.2 North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2023-2028)

6.3.3 North America Proliferative Diabetic Retinopathy Therapeutics Market Share by Application (2017-2028)

6.4 North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Country

6.4.1 North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2017-2022)

6.4.2 North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2023-2028)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe Proliferative Diabetic Retinopathy Therapeutics Market Size (2017-2028)

7.2 Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Type

7.2.1 Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2017-2022)

7.2.2 Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2023-2028)

7.2.3 Europe Proliferative Diabetic Retinopathy Therapeutics Market Share by Type (2017-2028)

7.3 Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Application

7.3.1 Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2017-2022)

7.3.2 Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2023-2028)

7.3.3 Europe Proliferative Diabetic Retinopathy Therapeutics Market Share by Application (2017-2028)

7.4 Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Country

7.4.1 Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2017-2022)

7.4.2 Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size (2017-2028)

8.2 Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Type

8.2.1 Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Share by Type (2017-2028)

8.3 Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Application

8.3.1 Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Share by Application (2017-2028)

8.4 Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Region

8.4.1 Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size (2017-2028)

9.2 Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Type

9.2.1 Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2017-2022)

9.2.2 Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2023-2028)

9.2.3 Latin America Proliferative Diabetic Retinopathy Therapeutics Market Share by Type (2017-2028)

9.3 Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Application

9.3.1 Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2017-2022)

9.3.2 Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2023-2028)

9.3.3 Latin America Proliferative Diabetic Retinopathy Therapeutics Market Share by Application (2017-2028)

9.4 Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Country

9.4.1 Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2017-2022)

9.4.2 Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size (2017-2028)

10.2 Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Type

10.2.1 Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Share by Type (2017-2028)

10.3 Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Application

10.3.1 Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Share by Application (2017-2028)

10.4 Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Country

10.4.1 Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 Acucela Inc

11.1.1 Acucela Inc Company Details

11.1.2 Acucela Inc Business Overview

11.1.3 Acucela Inc Proliferative Diabetic Retinopathy Therapeutics Introduction

11.1.4 Acucela Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2017-2022)

11.1.5 Acucela Inc Recent Developments

11.2 Aerie Pharmaceuticals Inc

11.2.1 Aerie Pharmaceuticals Inc Company Details

11.2.2 Aerie Pharmaceuticals Inc Business Overview

11.2.3 Aerie Pharmaceuticals Inc Proliferative Diabetic Retinopathy Therapeutics Introduction

11.2.4 Aerie Pharmaceuticals Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2017-2022)

11.2.5 Aerie Pharmaceuticals Inc Recent Developments

11.3 Antisense Therapeutics Ltd

11.3.1 Antisense Therapeutics Ltd Company Details

11.3.2 Antisense Therapeutics Ltd Business Overview

11.3.3 Antisense Therapeutics Ltd Proliferative Diabetic Retinopathy Therapeutics Introduction

11.3.4 Antisense Therapeutics Ltd Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2017-2022)

11.3.5 Antisense Therapeutics Ltd Recent Developments

11.4 Icon Bioscience Inc

11.4.1 Icon Bioscience Inc Company Details

11.4.2 Icon Bioscience Inc Business Overview

11.4.3 Icon Bioscience Inc Proliferative Diabetic Retinopathy Therapeutics Introduction

11.4.4 Icon Bioscience Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2017-2022)

11.4.5 Icon Bioscience Inc Recent Developments

11.5 Ohr Pharmaceutical Inc

11.5.1 Ohr Pharmaceutical Inc Company Details

11.5.2 Ohr Pharmaceutical Inc Business Overview

11.5.3 Ohr Pharmaceutical Inc Proliferative Diabetic Retinopathy Therapeutics Introduction

11.5.4 Ohr Pharmaceutical Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2017-2022)

11.5.5 Ohr Pharmaceutical Inc Recent Developments

11.6 PanOptica Inc

11.6.1 PanOptica Inc Company Details

11.6.2 PanOptica Inc Business Overview

11.6.3 PanOptica Inc Proliferative Diabetic Retinopathy Therapeutics Introduction

11.6.4 PanOptica Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2017-2022)

11.6.5 PanOptica Inc Recent Developments

11.7 Ribomic Inc

11.7.1 Ribomic Inc Company Details

11.7.2 Ribomic Inc Business Overview

11.7.3 Ribomic Inc Proliferative Diabetic Retinopathy Therapeutics Introduction

11.7.4 Ribomic Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2017-2022)

11.7.5 Ribomic Inc Recent Developments

11.8 ThromboGenics NV

11.8.1 ThromboGenics NV Company Details

11.8.2 ThromboGenics NV Business Overview

11.8.3 ThromboGenics NV Proliferative Diabetic Retinopathy Therapeutics Introduction

11.8.4 ThromboGenics NV Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2017-2022)

11.8.5 ThromboGenics NV Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Acucela Inc

Aerie Pharmaceuticals Inc.

Antisense Therapeutics Ltd

Icon Bioscience Inc

Ohr Pharmaceutical Inc

List of Tables

Table 1. Global Proliferative Diabetic Retinopathy Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

Table 2. Key Players of Ocriplasmin

Table 3. Key Players of PAN-90806

Table 4. Key Players of RBM-008

Table 5. Key Players of Squalamine Lactate

Table 6. Key Players of THR-687

Table 7. Key Players of Others

Table 8. Global Proliferative Diabetic Retinopathy Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

Table 9. Global Proliferative Diabetic Retinopathy Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

Table 10. Global Proliferative Diabetic Retinopathy Therapeutics Market Size by Region (2017-2022) & (US$ Million)

Table 11. Global Proliferative Diabetic Retinopathy Therapeutics Market Share by Region (2017-2022)

Table 12. Global Proliferative Diabetic Retinopathy Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)

Table 13. Global Proliferative Diabetic Retinopathy Therapeutics Market Share by Region (2023-2028)

Table 14. Proliferative Diabetic Retinopathy Therapeutics Market Trends

Table 15. Proliferative Diabetic Retinopathy Therapeutics Market Drivers

Table 16. Proliferative Diabetic Retinopathy Therapeutics Market Challenges

Table 17. Proliferative Diabetic Retinopathy Therapeutics Market Restraints

Table 18. Global Proliferative Diabetic Retinopathy Therapeutics Revenue by Players (2017-2022) & (US$ Million)

Table 19. Global Proliferative Diabetic Retinopathy Therapeutics Revenue Share by Players (2017-2022)

Table 20. Global Top Proliferative Diabetic Retinopathy Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Proliferative Diabetic Retinopathy Therapeutics as of 2021)

Table 21. Ranking of Global Top Proliferative Diabetic Retinopathy Therapeutics Companies by Revenue (US$ Million) in 2021

Table 22. Global 5 Largest Players Market Share by Proliferative Diabetic Retinopathy Therapeutics Revenue (CR5 and HHI) & (2017-2022)

Table 23. Key Players Headquarters and Area Served

Table 24. Key Players Proliferative Diabetic Retinopathy Therapeutics Product Solution and Service

Table 25. Date of Enter into Proliferative Diabetic Retinopathy Therapeutics Market

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2017-2022) & (US$ Million)

Table 28. Global Proliferative Diabetic Retinopathy Therapeutics Revenue Market Share by Type (2017-2022)

Table 29. Global Proliferative Diabetic Retinopathy Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)

Table 30. Global Proliferative Diabetic Retinopathy Therapeutics Revenue Market Share by Type (2023-2028)

Table 31. Global Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2017-2022) & (US$ Million)

Table 32. Global Proliferative Diabetic Retinopathy Therapeutics Revenue Share by Application (2017-2022)

Table 33. Global Proliferative Diabetic Retinopathy Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)

Table 34. Global Proliferative Diabetic Retinopathy Therapeutics Revenue Share by Application (2023-2028)

Table 35. North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2017-2022) & (US$ Million)

Table 36. North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2023-2028) & (US$ Million)

Table 37. North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2017-2022) & (US$ Million)

Table 38. North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2023-2028) & (US$ Million)

Table 39. North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2017-2022) & (US$ Million)

Table 40. North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2023-2028) & (US$ Million)

Table 41. Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2017-2022) & (US$ Million)

Table 42. Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2023-2028) & (US$ Million)

Table 43. Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2017-2022) & (US$ Million)

Table 44. Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2023-2028) & (US$ Million)

Table 45. Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2017-2022) & (US$ Million)

Table 46. Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2023-2028) & (US$ Million)

Table 47. Asia Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2017-2022) & (US$ Million)

Table 48. Asia Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2023-2028) & (US$ Million)

Table 49. Asia Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2017-2022) & (US$ Million)

Table 50. Asia Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2023-2028) & (US$ Million)

Table 51. Asia Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Region (2017-2022) & (US$ Million)

Table 52. Asia Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Region (2023-2028) & (US$ Million)

Table 53. Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2017-2022) & (US$ Million)

Table 54. Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2023-2028) & (US$ Million)

Table 55. Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2017-2022) & (US$ Million)

Table 56. Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2023-2028) & (US$ Million)

Table 57. Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2017-2022) & (US$ Million)

Table 58. Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2023-2028) & (US$ Million)

Table 59. Middle East and Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2017-2022) & (US$ Million)

Table 60. Middle East and Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Type (2023-2028) & (US$ Million)

Table 61. Middle East and Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2017-2022) & (US$ Million)

Table 62. Middle East and Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Application (2023-2028) & (US$ Million)

Table 63. Middle East and Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2017-2022) & (US$ Million)

Table 64. Middle East and Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Country (2023-2028) & (US$ Million)

Table 65. Acucela Inc Company Details

Table 66. Acucela Inc Business Overview

Table 67. Acucela Inc Proliferative Diabetic Retinopathy Therapeutics Product

Table 68. Acucela Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2017-2022) & (US$ Million)

Table 69. Acucela Inc Recent Developments

Table 70. Aerie Pharmaceuticals Inc Company Details

Table 71. Aerie Pharmaceuticals Inc Business Overview

Table 72. Aerie Pharmaceuticals Inc Proliferative Diabetic Retinopathy Therapeutics Product

Table 73. Aerie Pharmaceuticals Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2017-2022) & (US$ Million)

Table 74. Aerie Pharmaceuticals Inc Recent Developments

Table 75. Antisense Therapeutics Ltd Company Details

Table 76. Antisense Therapeutics Ltd Business Overview

Table 77. Antisense Therapeutics Ltd Proliferative Diabetic Retinopathy Therapeutics Product

Table 78. Antisense Therapeutics Ltd Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2017-2022) & (US$ Million)

Table 79. Antisense Therapeutics Ltd Recent Developments

Table 80. Icon Bioscience Inc Company Details

Table 81. Icon Bioscience Inc Business Overview

Table 82. Icon Bioscience Inc Proliferative Diabetic Retinopathy Therapeutics Product

Table 83. Icon Bioscience Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2017-2022) & (US$ Million)

Table 84. Icon Bioscience Inc Recent Developments

Table 85. Ohr Pharmaceutical Inc Company Details

Table 86. Ohr Pharmaceutical Inc Business Overview

Table 87. Ohr Pharmaceutical Inc Proliferative Diabetic Retinopathy Therapeutics Product

Table 88. Ohr Pharmaceutical Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2017-2022) & (US$ Million)

Table 89. Ohr Pharmaceutical Inc Recent Developments

Table 90. PanOptica Inc Company Details

Table 91. PanOptica Inc Business Overview

Table 92. PanOptica Inc Proliferative Diabetic Retinopathy Therapeutics Product

Table 93. PanOptica Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2017-2022) & (US$ Million)

Table 94. PanOptica Inc Recent Developments

Table 95. Ribomic Inc Company Details

Table 96. Ribomic Inc Business Overview

Table 97. Ribomic Inc Proliferative Diabetic Retinopathy Therapeutics Product

Table 98. Ribomic Inc Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2017-2022) & (US$ Million)

Table 99. Ribomic Inc Recent Developments

Table 100. ThromboGenics NV Company Details

Table 101. ThromboGenics NV Business Overview

Table 102. ThromboGenics NV Proliferative Diabetic Retinopathy Therapeutics Product

Table 103. ThromboGenics NV Revenue in Proliferative Diabetic Retinopathy Therapeutics Business (2017-2022) & (US$ Million)

Table 104. ThromboGenics NV Recent Developments

Table 105. Research Programs/Design for This Report

Table 106. Key Data Information from Secondary Sources

Table 107. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Proliferative Diabetic Retinopathy Therapeutics Market Share by Type: 2021 VS 2028

Figure 2. Ocriplasmin Features

Figure 3. PAN-90806 Features

Figure 4. RBM-008 Features

Figure 5. Squalamine Lactate Features

Figure 6. THR-687 Features

Figure 7. Others Features

Figure 8. Global Proliferative Diabetic Retinopathy Therapeutics Market Share by Application: 2021 VS 2028

Figure 9. Hospital Case Studies

Figure 10. Clinic Case Studies

Figure 11. Home Care Case Studies

Figure 12. Proliferative Diabetic Retinopathy Therapeutics Report Years Considered

Figure 13. Global Proliferative Diabetic Retinopathy Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028

Figure 14. Global Proliferative Diabetic Retinopathy Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028

Figure 15. Global Proliferative Diabetic Retinopathy Therapeutics Market Share by Region: 2021 VS 2028

Figure 16. Global Proliferative Diabetic Retinopathy Therapeutics Market Share by Players in 2021

Figure 17. Global Top Proliferative Diabetic Retinopathy Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Proliferative Diabetic Retinopathy Therapeutics as of 2021)

Figure 18. The Top 10 and 5 Players Market Share by Proliferative Diabetic Retinopathy Therapeutics Revenue in 2021

Figure 19. North America Proliferative Diabetic Retinopathy Therapeutics Market Size YoY (2017-2028) & (US$ Million)

Figure 20. North America Proliferative Diabetic Retinopathy Therapeutics Market Size Market Share by Type (2017-2028)

Figure 21. North America Proliferative Diabetic Retinopathy Therapeutics Market Size Market Share by Application (2017-2028)

Figure 22. North America Proliferative Diabetic Retinopathy Therapeutics Market Size Share by Country (2017-2028)

Figure 23. United States Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 24. Canada Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 25. Europe Proliferative Diabetic Retinopathy Therapeutics Market Size YoY (2017-2028) & (US$ Million)

Figure 26. Europe Proliferative Diabetic Retinopathy Therapeutics Market Size Market Share by Type (2017-2028)

Figure 27. Europe Proliferative Diabetic Retinopathy Therapeutics Market Size Market Share by Application (2017-2028)

Figure 28. Europe Proliferative Diabetic Retinopathy Therapeutics Market Size Share by Country (2017-2028)

Figure 29. Germany Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 30. France Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 31. U.K. Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 32. Italy Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 33. Russia Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 34. Nordic Countries Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 35. Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size YoY (2017-2028) & (US$ Million)

Figure 36. Asia Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size Market Share by Type (2017-2028)

Figure 37. Asia Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size Market Share by Application (2017-2028)

Figure 38. Asia Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size Share by Region (2017-2028)

Figure 39. China Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 40. Japan Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 41. South Korea Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 42. Southeast Asia Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 43. India Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 44. Australia Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

Figure 45. Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size YoY (2017-2028) & (US$ Million)

Figure 46. Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size Market Share by Type (2017-2028)

Figure 47. Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size Market Share by Application (2017-2028)

Figure 48. Latin America Proliferative Diabetic Retinopathy Therapeutics Market Size Share by Country (2017-2028)

Figure 49. Mexico Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 50. Brazil Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 51. Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size YoY (2017-2028) & (US$ Million)

Figure 52. Middle East and Africa Proliferative Diabetic Retinopathy Therapeutics Market Size Market Share by Type (2017-2028)

Figure 53. Middle East and Africa Proliferative Diabetic Retinopathy Therapeutics Market Size Market Share by Application (2017-2028)

Figure 54. Middle East and Africa Proliferative Diabetic Retinopathy Therapeutics Market Size Share by Country (2017-2028)

Figure 55. Turkey Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 56. Saudi Arabia Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 57. UAE Proliferative Diabetic Retinopathy Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 58. Acucela Inc Revenue Growth Rate in Proliferative Diabetic Retinopathy Therapeutics Business (2017-2022)

Figure 59. Aerie Pharmaceuticals Inc Revenue Growth Rate in Proliferative Diabetic Retinopathy Therapeutics Business (2017-2022)

Figure 60. Antisense Therapeutics Ltd Revenue Growth Rate in Proliferative Diabetic Retinopathy Therapeutics Business (2017-2022)

Figure 61. Icon Bioscience Inc Revenue Growth Rate in Proliferative Diabetic Retinopathy Therapeutics Business (2017-2022)

Figure 62. Ohr Pharmaceutical Inc Revenue Growth Rate in Proliferative Diabetic Retinopathy Therapeutics Business (2017-2022)

Figure 63. PanOptica Inc Revenue Growth Rate in Proliferative Diabetic Retinopathy Therapeutics Business (2017-2022)

Figure 64. Ribomic Inc Revenue Growth Rate in Proliferative Diabetic Retinopathy Therapeutics Business (2017-2022)

Figure 65. ThromboGenics NV Revenue Growth Rate in Proliferative Diabetic Retinopathy Therapeutics Business (2017-2022)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Proliferative Diabetic Retinopathy Therapeutics Market Insights, Forecast to 2028

Published Date: February 2022

Report Code: QYRE-Auto-10T514

Global Proliferative Diabetic Retinopathy Therapeutics Market Insights, Forecast to 2028

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-4O8609

Wed Apr 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-25I8231

Wed Apr 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-2M4266

Wed Apr 17 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-38E8328

Wed Apr 17 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions